Development
A regulator approves the first US mRNA flu vaccine
Claim
The FDA approved Moderna's mFlusiva, the first US mRNA flu shot, 27% better than a standard dose and re-matchable to a new strain in two to three months rather than six, while an engineered bean gum cut HPV by 93% in patient saliva.
Reported metric: +27% / -93% HPV
Reporting date: (not necessarily the event date)
Sources
Attribution and reporting linked by this record; links do not imply independent verification.
- Welcome to August 6, 2026 (theinnermostloop.substack.com)
Knowledge graphopen in browser →
Reported in
Cite or correct this record
Suggest a correction — opens a GitHub draft for you to review and submit.